Systematic quantitative characterization of cellular responses induced by multiple signals

BMC Systems Biology

Volumn 5, Issue , 2011, Pages

  Al Shyoukh, Ibrahim ^a,b   Yu, Fuqu ^a,c   Feng, Jiaying ^a   Yan, Karen ^a   Dubinett, Steven ^b   Ho, Chih Ming ^b   Shamma, Jeff S ^d   Sun, Ren ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^d GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; BIOLOGICAL MODEL; BIOLOGY; COMPUTER PROGRAM; DRUG SCREENING; GENE EXPRESSION REGULATION; HUMAN; METHODOLOGY; NEOPLASM; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; THEORETICAL MODEL; TUMOR CELL LINE;

ALGORITHMS; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NEOPLASMS; SIGNAL TRANSDUCTION; SOFTWARE; SYSTEMS BIOLOGY;

EID: 79957535629     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-5-88     Document Type: Article

References (44)

1. Janes KA, Albeck JG, Gaudet S, Sorger PK, Lauffenburger DA, Yaffe MB. A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science 2005, 310(5754):1646-1653. 10.1126/science.1116598, 16339439.
2. Janes KA, Yaffe MB. Data-driven modelling of signal-transduction networks. Nat Rev Mol Cell Biol 2006, 7(11):820-828. 10.1038/nrm2041, 17057752.
3. Irish JM, Kotecha N, Nolan GP. Mapping normal and cancer cell signalling networks: towards single-cell proteomics. Nat Rev Cancer 2006, 6(2):146-155. 10.1038/nrc1804, 16491074.
4. Natarajan M, Lin KM, Hsueh RC, Sternweis PC, Ranganathan R. A global analysis of cross-talk in a mammalian cellular signalling network. Nat Cell Biol 2006, 8(6):571-580. 10.1038/ncb1418, 16699502.
5. Berenbaum M. Direct search methods in the optimisation of cancer chemotherapy regimens. Br J Cancer 1990, 61:101-109. 10.1038/bjc.1990.22, 1971319, 2297481.
6. Curatolo M, Sveticic G. Drug combinations in pain treatment: a review of the published evidence and a method for finding the optimal combination. Best Practice & Research Clinical Anaesthesiology 2002, 16(4):507-519. 10.1053/bean.2002.0254, 21638054.
7. Wong PK, Yu F, Shahangian A, Cheng G, Sun R, Ho CM. Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm. Proc Natl Acad Sci USA 2008, 105(13):5105-10. 10.1073/pnas.0800823105, 2278193, 18356295.
8. Sun CP, Usui T, Yu F, Al-Shyoukh I, Shamma J, Sun R, Ho CM. Integrative systems control approach for reactivating Kaposi's sarcoma-associated herpesvirus (KSHV) with combinatory drugs. Integrative Biology 2009, 1:123-130. 10.1039/b815225j, 2765122, 19851479.
9. Calzolari D, Bruschi S, Coquin L, Schofield J, Feala J, Reed J, McCulloch A, Paternostro G. Search Algorithms as a Framework for the Optimization of Drug Combinations. PLOS Computational Biology 2008, 4(12):e1000249. 10.1371/journal.pcbi.1000249, 2590660, 19112483.
10. Iadevaia S, Lu Y, Morales FC, Mills GB, Ram PT. Identification of Optimal Drug Combinations Targeting Cellular Networks: Integrating Phospho-Proteomics and Computational Network Analysis. Cancer Research 2010, 70(17):6704-6714. 10.1158/0008-5472.CAN-10-0460, 20643779.
11. Feala J, Cortes J, Duxbury P, Piermarocchi C, McCulloch A, Paternostro G. Systems approaches and algorithms for discovery of combinatorial therapies. WIREs Syst Biol Med 2010, 2(2):181-193.
12. Mellor D, Prieto E, Mathieson L, Moscato P. A Kernelisation Approach for Multiple d-Hitting Set and Its Application in Optimal Multi-Drug Therapeutic Combinations. PLoS ONE 2010, 5(10):e13055. 10.1371/journal.pone.0013055, 2956629, 20976188.
13. Zinner RG, Barrett BL, Popova E, Damien P, Volgin AY, Gelovani JG, Lotan R, Tran HT, Pisano C, Mills GB, Mao L, Hong WK, Lippman SM, Miller JH. Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells. Molecular Cancer Therapeutics 2009, 8(3):521-532. 10.1158/1535-7163.MCT-08-0937, 19276160.
14. Mukherjee JS, Rich ML, Socci AR, Joseph JK, Virú FA, Shin SS, Furin JJ, Becerra MC, Barry DJ, Kim JY, Bayona J, Farmer P, Fawzi MCS, Seung KJ. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 2004, 363(9407):474-481. 10.1016/S0140-6736(04)15496-2, 14962530.
15. Richman DD. HIV chemotherapy. Nature 2001, 410(6831):995-1001. 10.1038/35073673, 11309630.
16. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001, 411(6835):342-348. 10.1038/35077213, 11357141.
17. Bellamy WT. Prediction of response to drug therapy of cancer. A review of in vitro assays. Drugs 1992, 44(5):690-708. 10.2165/00003495-199244050-00002, 1280562.
18. Jain AK, Mao J, Mohiuddin KM. Artificial Neural Networks: A Tutorial. IEEE Computer 1996, 29(3):31-44.
19. Gupta MM, Homma N, Jin L. Static and Dynamic Neural Networks: From Fundamentals to Advanced Theory 2003, New York, NY, USA: John Wiley & Sons, Inc.
20. Hartigan J. Clustering Algorithms 1975, NY. Wiley.
21. Afifi A, Clark VA, May S. Computer-Aided Multivariate Analysis 2003, Chapman & Hall/CRC, fourth.
22. Hofmann M, Gatu C, Kontoghiorghes E. Efficient algorithms for computing the best subset regression models for large-scale... Computational Statistics and Data Analysis 2007, , http://linkinghub.elsevier.com/retrieve/pii/S0167947307001168
23. Agatonovic-Kustrin S, Beresford R. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. J Pharm Biomed Anal 2000, 22(5):717-27. 10.1016/S0731-7085(99)00272-1, 10815714.
24. Bourquin J, Schmidli H, van Hoogevest P, Leuenberger H. Application of artificial neural networks (ANN) in the development of solid dosage forms. Pharm Dev Technol 1997, 2(2):111-21. 10.3109/10837459709022616, 9552437.
25. Bourquin J, Schmidli H, van Hoogevest P, Leuenberger H. Basic concepts of artificial neural networks (ANN) modeling in the application to pharmaceutical development. Pharm Dev Technol 1997, 2(2):95-109. 10.3109/10837459709022615, 9552436.
26. Chen HY, Chen TC, Min DI, Fischer GW, Wu YM. Prediction of tacrolimus blood levels by using the neural network with genetic algorithm in liver transplantation patients. Ther Drug Monit 1999, 21:50-6. 10.1097/00007691-199902000-00008, 10051054.
27. de Matas M, Shao Q, Richardson CH, Chrystyn H. Evaluation of in vitro in vivo correlations for dry powder inhaler delivery using artificial neural networks. Eur J Pharm Sci 2008, 33:80-90.
28. Lin CC, Wang YC, Chen JY, Liou YJ, Bai YM, Lai IC, Chen TT, Chiu HW, Li YC. Artificial neural network prediction of clozapine response with combined pharmacogenetic and clinical data. Comput Methods Programs Biomed 2008, 91(2):91-9. 10.1016/j.cmpb.2008.02.004, 18508152.
29. Papadourakis GM, Gaga E, Vareltzis G, Bebis G. Use of artificial neural networks for clinical decision-making (Maldescensus testis). Neural Networks, 1992. IJCNN. International Joint Conference on 1992, 3:159-164.
30. Payne SJ, Arrol HP, Hunt SV, Young SP. Automated classification and analysis of the calcium response of single T lymphocytes using a neural network approach. IEEE Trans Neural Netw 2005, 16(4):949-58. 10.1109/TNN.2005.849820, 16121735.
31. Penny W, Frost D. Neural networks in clinical medicine. Med Decis Making 1996, 16(4):386-98. 10.1177/0272989X9601600409, 8912300.
32. Sun Y, Peng Y, Chen Y, Shukla AJ. Application of artificial neural networks in the design of controlled release drug delivery systems. Adv Drug Deliv Rev 2003, 55(9):1201-15. 10.1016/S0169-409X(03)00119-4, 12954199.
33. Xie H, Gan Y, Ma S, Gan L, Chen Q. Optimization and evaluation of time-dependent tablets comprising an immediate and sustained release profile using artificial neural network. Drug Dev Ind Pharm 2008, 34(4):363-72. 10.1080/03639040701657701, 18401778.
34. Yamamura S, Kawada K, Takehira R, Nishizawa K, Katayama S, Hirano M, Momose Y. Prediction of aminoglycoside response against methicillin-resistant Staphylococcus aureus infection in burn patients by artificial neural network modeling. Biomed Pharmacother 2008, 62:53-8. 10.1016/j.biopha.2007.11.004, 18083323.
35. Miller-Jensen K, Janes KA, Brugge JS, Lauffenburger DA. Common effector processing mediates cell-specific responses to stimuli. Nature 2007, 448(7153):604-608. 10.1038/nature06001, 17637676.
36. Irish JM, Hovland R, Krutzik PO, Perez OD, Bruserud T, Gjertsen BT, Nolan GP. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 2004, 118(2):217-228. 10.1016/j.cell.2004.06.028, 15260991.
37. Andrews R, Diederich J, Tickle AB. Survey and critique of techniques for extracting rules from trained neural networks. Knowledge-based Systems 1996, 8:373-389.
38. Jacobsson H. Rule extraction from recurrent neural networks: A taxonomy and review. Neural Computation 2005, 17:1223-1263.
39. Kahramanli H, Allahverdi N. Rule extraction from trained adaptive neural networks using artificial immune systems. Expert Systems with Applications 2009, 36:1513-1522.
40. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JKV, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE. The Consensus Coding Sequences of Human Breast and Colorectal Cancers. Science 2006, 314(5797):268-274. 10.1126/science.1133427, 16959974.
41. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004, 10(8):789-799. 10.1038/nm1087, 15286780.
42. Sawyers CL. Cancer: Mixing cocktails. Nature 2007, 449(7165):993-996. 10.1038/449993a, 17960228.
43. Ramaswamy S. Rational design of cancer-drug combinations. N Engl J Med 2007, 357(3):299-300. 10.1056/NEJMcibr072593, 17634467.
44. Demuth H, Beale M, Hagan M. Neural Network Toolbox 6 User's Guide. The Mathworks inc 2010,